Picture of CellaVision AB logo

CEVI CellaVision AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for CellaVision AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line112158148164177
Depreciation
Non-Cash Items15.68.584.699.6222.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-56.7-40.6-55.9-17.2-41.6
Change in Accounts Receivable
Change in Inventories
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities71.1160137196198
Capital Expenditures-33.6-52.5-69.2-86.5-77.7
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items-1.37-31.8-0.7810.9441.74
Acquisition of Business
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-35-84.3-70-85.5-76
Financing Cash Flow Items-0.0010.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-35.2-48.5-90.4-97-95.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.05128-22.213.627.8